US 10106620
Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells
granted A61KA61K39/39558A61P
Quick answer
US patent 10106620 (Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K39/39558, A61P, A61P35/02, A61P37/00